期刊文献+

Growing applications of FDG PET-CT imaging in non-oncologic conditions 被引量:3

Growing applications of FDG PET-CT imaging in non-oncologic conditions
下载PDF
导出
摘要 As the number of clinical applications of 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET-CT) grows, familiarity with the conditions that can be diagnosed by this modality and when relevant pieces of additional information can be obtained becomes increasingly important for both requesting physicians and nuclear medicine physicians or radiologists who interpret the findings. Apart from its heavy use in clinical oncology, FDG PET-CT is widely used in a variety of non-oncologic con- ditions interconnecting to such disciplines as general internal medicine, infectious diseases, cardiology, neurology, surgery, traumatology, orthopedics, pediatrics, endocrinology, rheumatology, psychiatry, neuropsychology, and cognitive neuroscience. The aim of this review was to summarize the current evidence of FDG PET-CT applications in evaluating non-oncologic pathologies and the relevant information it can add to achieve a final diagnosis. As the number of clinical applications of 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography/computed tomography (PET-CT) grows, familiarity with the conditions that can be diagnosed by this modality and when relevant pieces of additional information can be obtained becomes increasingly important for both requesting physicians and nuclear medicine physicians or radiologists who interpret the findings. Apart from its heavy use in clinical oncology, FDG PET-CT is widely used in a variety of non-oncologic con- ditions interconnecting to such disciplines as general internal medicine, infectious diseases, cardiology, neurology, surgery, traumatology, orthopedics, pediatrics, endocrinology, rheumatology, psychiatry, neuropsychology, and cognitive neuroscience. The aim of this review was to summarize the current evidence of FDG PET-CT applications in evaluating non-oncologic pathologies and the relevant information it can add to achieve a final diagnosis.
出处 《The Journal of Biomedical Research》 CAS CSCD 2015年第3期189-202,共14页 生物医学研究杂志(英文版)
关键词 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) non-oncologic inflammation infection 18F-fluorodeoxyglucose (FDG), positron emission tomography (PET), computed tomography (CT), non-oncologic, inflammation, infection
  • 相关文献

参考文献111

  • 1Glaudemans AW, de Vries EF, Galli F, et al. The Use of F-FDG-PET/CT for Diagnosis and Treatment Monitoring of Inflammatory and Infectious Diseases[J]. Clin Dev Immunol, 2013, 623036.
  • 2Stumpe KD, Strobel K. 18F FDG-PET imaging in muscu- loskeletal infection[J]. Q J Nucl Med Mol Imaging, 2006,50(2): 131-142.
  • 3Bomanji J, Almuhaideb A, Zumla A. Combined PET and X-ray computed tomography imaging in pulmonary infec- tions and inflammation[J]. Curr Opin Pulm Med, 2011,17(3): 197-205.
  • 4Chakrabarti R, Jung CY, ~ TP, et al. Changes in glucose transport and transporter isoforms during the activation of human peripheral blood lymphocytes by phytohemag- glufinin[J]. J Immunol, 1994,152(6):2660-2668.
  • 5Kubota R, Yamada S, Kubota K, et al. Intratumoral distri- bution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography[J]. J Nucl Med, 1992,33(11):1972-1980.
  • 6Meller J, Sahlmann CO, Scheel AK. 18F-FDG PET and PET/CT in fever of unknown origin[J]. J Nucl Med, 2007,48(1):35-45.
  • 7Osman S, Danpure HJ. The use of 2-[18F]fluoro-2-deoxy- D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography[J]. Int J Rad Appl Instrum B, 1992,19(2):183- 190.
  • 8Rini JN, Palestro CJ. Imaging of infection and inflamma- tion with 18F-FDG-labeled leukocytes[J]. Q J Nucl Med Mol Imaging, 2006,50(2):143-146.
  • 9Yu JQ, Doss M, Codreanu I, et al. PET/CT in Patients with Sarcoidosis or IgG4 Disease[J[. PET Clinics, 2012,7(2): 191-210.
  • 10Kumar A, Chugani HT. The Role of Radionuclide Imaging in Epilepsy, Part 2: Epilepsy Syndromes[J]. J Nucl Med, 2013, 54(11):1924-1930.

同被引文献7

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部